In colorectal cancer, relevant studies have found that patients with low CPNE3 levels in exosomes have significantly better disease‐free survival and overall survival, suggesting that CPNE3 may be used as a biomarker to diagnose and evaluate the prognosis of colorectal cancer [14, 15]. This evidence concerns the gene CPNE3 and colorectal cancer.